Soyoung Kim, PhD

Publications

• Statistical Methods for Time-Dependent Variables in Hematopoietic Cell Transplantation Studies.

  (Kim S, Logan B, Riches M, Chen M, Ahn KW.) Transplant Cell Ther. 2021 02;27(2):125-132 PMID: 33017663 PMCID: PMC8015678 SCOPUS ID: 2-s2.0-85093960710 10/06/2020

• Genetic factors rather than blast reduction determine outcomes of allogeneic HCT in BCR-ABL-negative MPN in blast phase.

  (Gupta V, Kennedy JA, Capo-Chichi JM, Kim S, Hu ZH, Alyea EP, Popat UR, Sobecks RM, Scott BL, Gerds AT, Salit RB, Deeg HJ, Nakamura R, Saber W.) Blood Adv. 2020 11 10;4(21):5562-5573 PMID: 33170935 PMCID: PMC7656913 SCOPUS ID: 2-s2.0-85097009206 11/11/2020

• Comparison of outcomes of HCT in blast phase of BCR-ABL1- MPN with de novo AML and with AML following MDS.

  (Gupta V, Kim S, Hu ZH, Liu Y, Aljurf M, Bacher U, Beitinjaneh A, Cahn JY, Cerny J, Copelan E, Gadalla SM, Gale RP, Ganguly S, George B, Gerds AT, Gergis U, Hamilton BK, Hashmi S, Hildebrandt GC, Kamble RT, Kindwall-Keller T, Lazarus HM, Liesveld JL, Litzow M, Maziarz RT, Nishihori T, Olsson RF, Rizzieri D, Savani BN, Seo S, Solh M, Szer J, Verdonck LF, Wirk B, Woolfrey A, Yared JA, Alyea EP, Popat UR, Sobecks RM, Scott BL, Nakamura R, Saber W.) Blood Adv. 2020 10 13;4(19):4748-4757 PMID: 33007075 PMCID: PMC7556156 SCOPUS ID: 2-s2.0-85092401454 10/03/2020

• Collection of Peripheral Blood Progenitor Cells in 1 Day Is Associated with Decreased Donor Toxicity Compared to 2 Days in Unrelated Donors.

  (Hsu JW, Shaw BE, Kim S, Logan BR, Sees JA, Confer DL, Pulsipher MA, Shah N, Switzer GE, Abidi MH, Ahmed IA, Anderlini PN, Bredeson C, Chhabra S, Dandoy CE, Diaz MA, Farhadfar N, Ganguly S, Gergis U, Hale GA, Hematti P, Kamble RT, Kasow KA, Lazarus HM, Liesveld JL, Murthy HS, Olsson RF, Savani BN, Schears R, Seo S, Solh M, Spitzer T, Steinberg A, Sugrue M, Warkentin P, Wingard JR.) Biol Blood Marrow Transplant. 2020 06;26(6):1210-1217 PMID: 32088366 PMCID: PMC7347029 SCOPUS ID: 2-s2.0-85082823451 02/24/2020

• Late effects after ablative allogeneic stem cell transplantation for adolescent and young adult acute myeloid leukemia.

  (Lee CJ, Kim S, Tecca HR, Bo-Subait S, Phelan R, Brazauskas R, Buchbinder D, Hamilton BK, Battiwalla M, Majhail NS, Lazarus HM, Shaw PJ, Marks DI, Litzow MR, Chhabra S, Inamoto Y, DeFilipp Z, Hildebrandt GC, Olsson RF, Kasow KA, Liesveld JL, Rotz SJ, Badawy SM, Bhatt NS, Yared JA, Page KM, Arellano ML, Kent M, Farhadfar N, Seo S, Hematti P, Freytes CO, Rovó A, Ganguly S, Nathan S, Burns L, Shaw BE, Muffly LS.) Blood Adv. 2020 03 24;4(6):983-992 PMID: 32168378 PMCID: PMC7094022 SCOPUS ID: 2-s2.0-85082533373 03/14/2020

• Incidence, Risk Factors, and Outcomes of Patients Who Develop Mucosal Barrier Injury-Laboratory Confirmed Bloodstream Infections in the First 100 Days After Allogeneic Hematopoietic Stem Cell Transplant.

  (Dandoy CE, Kim S, Chen M, Ahn KW, Ardura MI, Brown V, Chhabra S, Diaz MA, Dvorak C, Farhadfar N, Flagg A, Ganguly S, Hale GA, Hashmi SK, Hematti P, Martino R, Nishihori T, Nusrat R, Olsson RF, Rotz SJ, Sung AD, Perales MA, Lindemans CA, Komanduri KV, Riches ML.) JAMA Netw Open. 2020 01 03;3(1):e1918668 PMID: 31913492 PMCID: PMC6991246 SCOPUS ID: 2-s2.0-85077688075 01/09/2020

• Stratified proportional subdistribution hazards model with covariate-adjusted censoring weight for case-cohort studies

  (Kim S, Xu Y, Zhang MJ, Ahn KW.) Scandinavian Journal of Statistics. December 2020;47(4):1222-1242 SCOPUS ID: 2-s2.0-85085067973 12/01/2020

• Comparison of outcomes of HCT in blast phase of BCR-ABL12 MPN with de novo AML and with AML following MDS

  (Gupta V, Kim S, Hu ZH, Liu Y, Aljurf M, Bacher U, Beitinjaneh A, Cahn JY, Cerny J, Copelan E, Gadalla SM, Gale RP, Ganguly S, George B, Gerds AT, Gergis U, Hamilton BK, Hashmi S, Hildebrandt GC, Kamble RT, Kindwall-Keller T, Lazarus HM, Liesveld JL, Litzow M, Maziarz RT, Nishihori T, Olsson RF, Rizzieri D, Savani BN, Seo S, Solh M, Szer J, Verdonck LF, Wirk B, Woolfrey A, Yared JA, Alyea EP, Popat UR, Sobecks RM, Scott BL, Nakamura R, Saber W.) Blood Advances. 13 October 2020;4(19):4748-4757 SCOPUS ID: 2-s2.0-85092401454 10/13/2020

• Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia.

  (Bejanyan N, Kim S, Hebert KM, Kekre N, Abdel-Azim H, Ahmed I, Aljurf M, Badawy SM, Beitinjaneh A, Boelens JJ, Diaz MA, Dvorak CC, Gadalla S, Gajewski J, Gale RP, Ganguly S, Gennery AR, George B, Gergis U, Gómez-Almaguer D, Vicent MG, Hashem H, Kamble RT, Kasow KA, Lazarus HM, Mathews V, Orchard PJ, Pulsipher M, Ringden O, Schultz K, Teira P, Woolfrey AE, Saldaña BD, Savani B, Winiarski J, Yared J, Weisdorf DJ, Antin JH, Eapen M.) Blood Adv. 2019 10 22;3(20):3123-3131 PMID: 31648332 PMCID: PMC6849938 SCOPUS ID: 2-s2.0-85075150491 10/28/2019

• Survival outcomes of allogeneic hematopoietic cell transplants with EBV-positive or EBV-negative post-transplant lymphoproliferative disorder, A CIBMTR study.

  (Naik S, Riches M, Hari P, Kim S, Chen M, Bachier C, Shaughnessy P, Hill J, Ljungman P, Battiwalla M, Chhabra S, Daly A, Storek J, Ustun C, Diaz MA, Cerny J, Beitinjaneh A, Yared J, Brown V, Page K, Dahi PB, Ganguly S, Seo S, Chao N, Freytes CO, Saad A, Savani BN, Woo Ahn K, Boeckh M, Heslop HE, Lazarus HM, Auletta JJ, Kamble RT.) Transpl Infect Dis. 2019 Oct;21(5):e13145 PMID: 31301099 PMCID: PMC7239317 SCOPUS ID: 2-s2.0-85073491232 07/14/2019

• Related and unrelated donor transplantation for β-thalassemia major: results of an international survey.

  (Li C, Mathews V, Kim S, George B, Hebert K, Jiang H, Li C, Zhu Y, Keesler DA, Boelens JJ, Dvorak CC, Agarwal R, Auletta JJ, Goyal RK, Hanna R, Kasow K, Shenoy S, Smith AR, Walters MC, Eapen M.) Blood Adv. 2019 09 10;3(17):2562-2570 PMID: 31471325 PMCID: PMC6737407 SCOPUS ID: 2-s2.0-85072156526 09/01/2019

• Increased overall and bacterial infections following myeloablative allogeneic HCT for patients with AML in CR1.

  (Ustun C, Kim S, Chen M, Beitinjaneh AM, Brown VI, Dahi PB, Daly A, Diaz MA, Freytes CO, Ganguly S, Hashmi S, Hildebrandt GC, Lazarus HM, Nishihori T, Olsson RF, Page KM, Papanicolaou G, Saad A, Seo S, William BM, Wingard JR, Wirk B, Yared JA, Perales MA, Auletta JJ, Komanduri KV, Lindemans CA, Riches ML.) Blood Adv. 2019 09 10;3(17):2525-2536 PMID: 31471322 PMCID: PMC6737406 SCOPUS ID: 2-s2.0-85072110353 09/01/2019